SCHEMBL30962677

SCHEMBL30962677

COc1nc(Cl)ncc1C(=O)Nc1c(C)ccc(O[Si](C)(C)C(C)(C)C)c1C

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 5/20 0.37
▸ ATF1 P18846 3/20 0.37
▸ LCK P06239 3/20 0.36
▸ PDE4D Q08499 9/20 0.36
▸ PDE4B Q07343 9/20 0.36
▸ PDE4A P27815 8/20 0.36
▸ PDE4C Q08493 8/20 0.36
▸ PDE11A Q9HCR9 2/20 0.35
▸ PDE3B Q13370 1/20 0.35
▸ JUN P05412 2/20 0.35
▸ NFKB2 Q00653 2/20 0.35
▸ RELA Q04206 2/20 0.35
▸ XPO1 O14980 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34
▸ MAPK14 Q16539 2/20 0.34
▸ KDR P35968 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962773 0.92 PDE4D (0.38) NFKB1ATF1PDE4DPDE4BPDE4A
SCHEMBL30962633 0.89 NFKB1 (0.42) NFKB1ATF1LCKPDE4DPDE4B
SCHEMBL30962738 0.86 PDE4D (0.39) NFKB1ATF1PDE4DPDE4BPDE4A
SCHEMBL30962658 0.81 NFKB1 (0.42) NFKB1ATF1PDE4DPDE4BPDE4A
SCHEMBL30962603 0.80 JAK3 (0.42) LCKMAPK14KDR
SCHEMBL31737736 0.78 PDE4D (0.44) NFKB1ATF1PDE4DPDE4BPDE4A
SCHEMBL30962609 0.74 NFKB1 (0.43) NFKB1ATF1PDE4DPDE4BPDE4A
SCHEMBL31737724 0.73 PDE4D (0.42) PDE4DPDE4BPDE4APDE4CPDE11A
SCHEMBL30962863 0.73 NFKB1 (0.42) NFKB1ATF1PDE4DPDE4BPDE4A
SCHEMBL30962730 0.73 POLB (0.46) NFKB1ATF1PDE4DPDE4BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback